Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)
Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and pharmacokinetics of HL068 (Candesartan
16 mg and Amlodipine 10mg) with coadministration of the two separate drugs in healthy male
volunteers.